Empower: tDCS for Major Depressive Disorder at Home
NCT: NCT05202119 · COMPLETED
Реклама
NCT IDNCT05202119
СтатусCOMPLETED
Дата начала2022-05-12
Завершение2023-08-31
Краткое описание
A two-center trial to investigate whether or not active stimulation with the Flow FL-100 tDCS device is superior to sham stimulation for the treatment of major depressive disorder when used at home. Participants perform up to 36 tDCS sessions by themselves without supervision during a blinded 10-week phase, and then 30 more sessions during an unblinded open-label phase.
Официальный источник
Открыть на ClinicalTrials.gov →Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.